New androgen receptor genomic targets show an interaction with the ETS1 transcription factor
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The androgen receptor (AR) initiates important developmental and oncogenic transcriptional pathways. The AR is known to bind as a homodimer to 15-base pair bipartite palindromic androgen-response elements; however, few direct AR gene targets are known. To identify AR promoter targets, we used chromatin immunoprecipitation with on-chip detection of genomic fragments. We identified 1,532 potential AR-binding sites, including previously known AR gene targets. Many of the new AR target genes show altered expression in prostate cancer. Analysis of sequences underlying AR-binding sites showed that more than 50% of AR-binding sites did not contain the established 15 bp AR-binding element. Unbiased sequence analysis showed 6-bp motifs, which were significantly enriched and were bound directly by the AR in vitro. Binding sequences for the avian erythroblastosis virus E26 homologue (ETS) transcription factor family were also highly enriched, and we uncovered an interaction between the AR and ETS1 at a subset of AR promoter targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such a situation has also been observed for similar studies on the androgen receptor and may suggest compensation or redundancy in transcriptional control (Massie et al., 2007).”
From Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence (2010) · cites this paper as Massie et al., 2007
In the citing paper
“The involvement of the AR in normal prostate development, coupled with the prevalence of ETS-binding sequences at AR-bound regions (177), implies a cooperative interaction that could play a role in ETS-mediated prostate oncogenesis (Figure 7).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [177]
In the citing paper
“AR has evolved in a manner that allows it to tolerate levels of sequence degeneracy for proper development, with this enhanced flexibility conferred through a plastic dimer interface and an extended hinge, both serving as regulatory mechanisms that allow AR to bind primarily half sites and other degenerate sequences in vivo”
From Allosteric interactions prime androgen receptor dimerization and activation (2022) · cites this paper as Massie et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278 · cited 3×
“EMBO open New androgen receptor genomic targets show an interaction with the ETS1 transcription factor”
BackgroundMatInspector and beyond: promoter analysis based on transcription factor binding sites
Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M., & Werner, T. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti473 · Cited by 1,979
Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.008 · Cited by 1,384
Cancer incidence and mortality in Europe, 2004
Boyle, P., & Ferlay, J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi098 · Cited by 1,217
Cancer incidence and mortality in Europe
Levi, F., Maisonneuve, P., Filiberti, R., La Vecchia, C., & Boyle, P. (1989) · Sozial- und Präventivmedizin · doi:10.1007/bf02148558 · Cited by 968
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.001 · Cited by 800
Holzbeierlein, J., Lal, P., LaTulippe, E., Smith, A., Satagopan, J., Zhang, L., Ryan, C., Smith, S., Scher, H., Scardino, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63112-4 · Cited by 577 · cited 1×
“Gene Ontology analysis Oncogenomics Haag et al (2005) Velsaco et al (2004) Holzbeierlein et al (2004) Varambally et al (2005) A”
Hata, A., Seoane, J., Lagna, G., Montalvo, E., Hemmati-Brivanlou, A., & Massagué, J. (2000) · Cell · doi:10.1016/s0092-8674(00)81561-5 · Cited by 420
Cited by
Items 201–259 of 259
Todorova, K. O., Zasheva, D., Kanev, K., & Hayrabedyan, S. (2014) · Journal of Cancer Research · doi:10.1155/2014/840906 · Cited by 5
Structural perspectives on the androgen receptor, the elusive shape-shifter
Johnson, M. J., & Wasmuth, E. V. (2024) · Steroids · doi:10.1016/j.steroids.2024.109501 · Cited by 6
Uncovering Androgen Responsive Regulatory Networks in Prostate Cancer
Eisermann, K., Bazarov, A., Brett, A., Knapp, E., Piontkivska, H., & Fraizer, G. C. (2009) · Ohio Collaborative Conference on Bioinformatics (OCCBIO) · doi:10.1109/occbio.2009.21 · Cited by 4
The Role of Androgen-Regulated Long Noncoding RNAs in Prostate Cancer
Takayama, K., & Inoue, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55576-6_11 · Cited by 3
Androgen-Regulated Genes in the Prostate
Clegg, N. J., & Nelson, P. S. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_27 · Cited by 3
Androgen Receptor in Health and Disease
Marcelli, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_2 · Cited by 3
BioSAVE: Display of scored annotation within a sequence context
Pollock, R. F., & Adryan, B. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-157 · Cited by 3
Self-citationSteroid Hormone Receptor Signaling
Giguère, V. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00246-1 · Cited by 4
Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells
Chen, C., Dienhart, J. A., & Bolton, E. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156145 · Cited by 3
“data in HRTBLDb using R1881-treated LNCaP cells reveal an AR-occupied region 81 kb downstream of the AIFM2 TSS as a putative site of AR regulation [94].”
BackgroundCompetitive and compensatory effects of androgen signaling and glucocorticoid signaling
Harada, N., Inui, H., & Yamaji, R. (2015) · Receptors & Clinical Investigation · doi:10.14800/rci.785 · Cited by 2
Selective and Classical Androgen Response Elements in Androgen-Regulated Gene Expression
Claessens, F., Clinckemalie, L., Helsen, C., Spans, L., Dubois, V., Laurent, M. R., Boonen, S., & Vanderschueren, D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_2 · Cited by 3
The Role of ETS Transcriptional Regulation in Hormone Sensitive and Refractory Prostate Cancer
Turner, D. P. (2010) · The Open Cancer Journal · doi:10.2174/1874079001003010040 · Cited by 2
“Significantly, analysis of the AR bound sequences demonstrated that around 70% of the AR promoter binding sites were adjacent to sequence motifs for ETS transcription factors (GGAAAC and GGAACT) [31].”
BackgroundInfluentialFusion transcripts: hopes and pitfalls in tranquilizing the trouble mongers in prostate cancer
Farooqi, A. A., & Bhatti, S. (2011) · Journal of Experimental and Integrative Medicine · doi:10.5455/jeim.060211.rw.001 · Cited by 2
“In the absence of androgen and overexpression of ETS there is an enhanced association of ETS with AR that results in a remarkable shuttling of the receptor into the nucleus thus enhancing its dwell time in the nucleus which consequently upregulates the expression of various genes [8].”
BackgroundIndependence of HIF1a and androgen signaling pathways in prostate cancerPreprint
Tran, M. G. B., Bibby, B. A. S., Yang, L., Lo, F., Warren, A. Y., Shukla, D., Osborne, M., Hadfield, J., Carroll, T., Stark, R., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/848424 · Cited by 2
Self-citationCanonical AREs are tumor suppressive regulatory elements in the prostatePreprint
Augello, M. A., Chen, X., Liu, D., Lin, K., Hakansson, A., Sjöström, M., Khani, F., Deonarine, L. D., Liu, Y., Travascio-Green, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.23.581466 · Cited by 2
“2c), and ARE was the most significantly enriched motif, followed by lower affinity variants of the ARE such as AR-halfsites 17,18 ( Fig.”
BackgroundAndrogen Receptor in Health and Disease
Hohl, A., & Marcelli, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_2 · Cited by 2
Ets-1 Protein Interactors in Transcriptional Activity Regulation
Choul‐li, S., & Aumercier, M. (2025) · Current Molecular Biology Reports · doi:10.1007/s40610-025-00165-4 · Cited by 1
“It has been shown that Ets-1 can also interact with AR at the CCNG2 and UNQ9419 promoters [63].”
Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders
Li, F., Chen, Q., Dai, Y., & Lu, L. (2025) · iScience · doi:10.1016/j.isci.2025.114042 · Cited by 1
Chromatin Remodeling and Androgen Receptor-Mediated Transcription
Li, J., Khalid, O. S., Frenkel, B., & Coetzee, G. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_18 · Cited by 1
Androgens and the androgen receptor (AR)
Moore, N. L. T., Centenera, M. M., Butler, L. M., Hickey, T. E., & Tilley, W. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.033 · Cited by 1
Hsiao, J. J., Smits, M. M., Ng, B. H., Lee, J., & Wright, M. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-01554-2 · Cited by 1
Vuong, W., Tew, B. Y., Little, G. H., Frenkel, B., & Jones, J. O. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.234567 · Cited by 1
“These changes, mediated by AR coactivators and collaborating transcription factors, are associated with redistribution of AR across the genome and alterations to its transcriptional regulation (Massie et al., 2007; Wang et al., 2007; Jia et al., 2008; Baniwal et al., 2009; Sahu et al., 2011).”
BackgroundMapping the Androgen Receptor Cistrome
Wang, Q., & Brown, M. A. (2009) · Springer eBooks · doi:10.1007/978-0-387-69179-4_28 · Cited by 2
Clarification of NICE Guidance on Prostate Cancer
Neal, D. E., McLoughlin, J., Anderson, J., Fawcett, D. P., & Kockelbergh, R. C. (2009) · British Journal of Medical and Surgical Urology · doi:10.1016/j.bjmsu.2009.09.001 · Cited by 1
Self-citationLee, P., Decker, J. T., Shea, L. D., & Beard, D. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.13.422572 · Cited by 1
WITHDRAWN: A Temporal Atlas of the Nuclear Androgen Receptor Proximal InteractomePreprint
Ptak, C. C., Eng, J. K., Radoshevich, L., & Wright, M. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.03.742470 · Cited by 2
The role of 8q amplification and microRNAs in prostate cancer
Jalava, S. E. (2012) · Tampere University Institutional Repository (Tampere University)
Reptides and Proteins Interacting with the Androgen Receptor
van de Wijngaart, D. J. (2009)
Chromatin Looping and Long Distance Regulation by Androgen Receptor
Sunkel, B. D., & Wang, Q. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6182-1_4
Role of JARID1 histone demethylases in modulating steroid receptor function
Stratmann, A. (2010) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-11322
Androgen Receptor Action in the Central Nervous System
Heemers, H. V., & Tindall, D. J. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00038-3
Molecular mechanisms of androgen receptor functions
Steketee, K. (2007) · RePub (Erasmus University Rotterdam) · Cited by 1
Overexpression of Androgen Receptor in Prostate Cancer
Urbanucci, A. (2012) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Tavakoli, I. (2013) · cIRcle (University of British Columbia) · doi:10.14288/1.0072850 · Cited by 2
“8 multiple transcription factors are located in these regions [73-76].”
BackgroundNovel Research on Fusion Genes and Next-Generation Sequencing
Abbosh, P. H., & Chen, D. Y. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800077-9.00004-9
Characterisation of a dominant negative androgen receptor in prostate cancer cells.
Centenera, M. M. (2008) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Methods to Identify Chromatin-Bound Protein Complexes: From Genome-Wide to Locus-Specific Approaches
Massie, C. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3724-0_9
Self-citationThe androgen receptor: basic structure and function
Plouffe, L. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139649520.007
Androgen Mediated Regulation of VEGF in Prostate Cancer
Eisermann, K. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Androgen receptor-mediated growth suppression and apoptosis of human prostate epithelial cells
Chen, C. (2016) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Characterization of Myopathy in Mice Overexpressing Androgen Receptor in Skeletal Muscle
Musa, M. (2010) · TSpace (University of Toronto)
New Mechanism Based Approaches For Treating Prostate Cancer
Rosati, R. (2017) · Human Biology
da Silva, L. F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.95.2019.tde-19042019-201105
Development of novel androgen receptor inhibitors to overcome castrate-resistant prostate cancer
Saraç, H., Cherkasov, A. R., & Lack, N. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821310-0.00007-3
Kaldis, P. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.3090956.2774054
Shin, S., Kim, T., Jin, F., van Deursen, J. M., Dehm, S. M., Tindall, D. J., Grande, J. P., Munz, J.-M., Vasmatzis, G., & Janknecht, R. (2023) · doi:10.1158/0008-5472.c.6499190.v1
Heemers, H. V., Schmidt, L. J., Sun, Z., Regan, K. M., Anderson, S. K., Duncan, K., Wang, D., Liu, S., Ballman, K. V., & Tindall, D. J. (2023) · doi:10.1158/0008-5472.c.6503106.v1
Lin, C., Yin, Y., Stemler, K. M., Humphrey, P. A., Kibel, A. S., Mysorekar, I. U., & Ma, L. (2023) · doi:10.1158/0008-5472.22398033
Lin, C., Yin, Y., Stemler, K. M., Humphrey, P. A., Kibel, A. S., Mysorekar, I. U., & Ma, L. (2023) · doi:10.1158/0008-5472.22398033.v1
Tereshchenko, Y. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10407
Androgenrezeptor in Gesundheit und Krankheit
Hohl, A., & Marcelli, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_2
Where Does Testosterone Come from and How Does It Act?
Smith, L. B., & McEwan, I. J. (2013) · SpringerBriefs in reproductive biology · doi:10.1007/978-1-4614-8978-8_3 · Cited by 1
Susa, T., Tsuboi, E., Okada, T., Akimoto, M., Okudaira, N., Okinaga, H., Iizuka, M., Okazaki, T., & Tamamori‐Adachi, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041962
“These results suggest that stably expressed HOXC9 autonomously binds to the HOXC9-binding site in the vicinity of the AR-binding sequence in LNCaP-C9 cells, because the HOXC9 consensus sequence (T/ATTAT) [33] was identified near each AR half-site (AGAACT/A) [34] (Figure S7).”
Identification et caractérisation de nouveaux partenaires du facteur de transcription ERM
Verreman, K. (2009) · theses.fr (ABES) · doi:10.70675/bf47548ezef04z448az86a3zbfc948ca93fe
Luo, B., Zhang, Q., Yang, X., Tan, Z., Qin, L., Yang, Y., Jokela, R., Giannareas, N., Manninen, A., & Wei, G. (2026) · iScience · doi:10.1016/j.isci.2026.117064
Chng, K. R., Chuah, S. C., & Cheung, E. C. W. (2011) · Springer eBooks · doi:10.1007/978-94-007-2801-1_8
“In addition to the above co-factors, the consensus binding sequences for the ETS (avian erythroblastosis virus E26 homologue) family of transcription factors were found enriched in 70% of AR-associated promoters in LNCaP cells [ 24 ] .”
Metadata
- Authors
- Massie, C. E., Adryan, B., Barbosa‐Morais, N. L., Lynch, A. G., Tran, M. G., Neal, D. E., & Mills, I. G.
- Affiliations
- University of Cambridge (GB)
- MRC Laboratory of Molecular Biology (GB)
- Corresponding author
- Massie, Charles E
- Mills, Ian G
- ORCID
- Venue
- The EMBO Reports
- Published
- 2007-08-17
- Volume
- 8
- Issue
- 9
- Pages
- 871-878
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC1950328
- OpenAlex
- W2030465046
- Cited by
- 259
- References
- 25
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 9 · 2017: 15 · 2016: 13 · 2015: 12 · 2014: 14 · 2013: 27 · 2012: 24
- FWCI
- 19.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Funders
- National Institute for Health and Care Research (CL-2006-14-006)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- androgen receptor, ETS1, transcription factor binding sites, androgen response element, prostate cancer, transcriptional regulation, protein-protein interaction
- MeSH terms
- Base Sequence, Binding Sites, Humans, Molecular Sequence Data, Promoter Regions, Genetic, Protein Binding, Receptors, Androgen, Genome, Human, Sequence Analysis, DNA, Cell Line, Tumor, Chromatin Immunoprecipitation, Proto-Oncogene Protein c-ets-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.